Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group

Lignende værker

• Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
  af: Carmelo Rizzari, et al.
  Udgivet: (2019-09-01)
• Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group
  af: Mariella D’Angiò, et al.
  Udgivet: (2015-01-01)
• Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol
  af: Carmelo Rizzari, et al.
  Udgivet: (2023-06-01)
• Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts
  af: Sabina Chiaretti, et al.
  Udgivet: (2013-11-01)
• Results in pediatric T‐ALL patients treated in trial AIEOP‐BFM ALL 2009: Prognostic factors in the context of modern risk‐adapted therapy
  af: Gunnar Cario, et al.
  Udgivet: (2025-09-01)